Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Cornblath

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
The Lancet. Neurology|May 12, 2019
Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathyCarina Bunschoten, Bart C Jacobs, Peter Y K Van den Bergh, et al.
Journal of Clinical Neuromuscular Disease|January 27, 2009
Peripheral nerve vasculitis presenting as complex regional pain syndromeSindhu Ramchandren, Vinay Chaudhry, Ahmet Hoke, et al.
Journal of the Peripheral Nervous System : JPNS|August 29, 2018
Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trialChrista Walgaard, Bart C Jacobs, Hester F Lingsma, et al.
Journal of the Peripheral Nervous System : JPNS|January 26, 2020
Boundaries of chronic inflammatory demyelinating polyradiculoneuropathyPeter Y K Van den Bergh, Pieter A van Doorn, Bart C Jacobs, et al.
Journal of the Peripheral Nervous System : JPNS|June 21, 2013
Rapid worsening of IgM anti-MAG demyelinating polyneuropathy during rituximab treatmentAbraham C J Stork, Nicolette C Notermans, Alexander F J E Vrancken, et al.
Vaccine|October 18, 2011
Guillain-Barré Syndrome in India: population-based validation of the Brighton criteriaFarrah J Mateen, David R Cornblath, Hamid Jafari, et al.
Brain : a Journal of Neurology|January 17, 2022
Randomized trial of three IVIg doses for treating chronic inflammatory demyelinating polyneuropathyDavid R Cornblath, Pieter A van Doorn, Hans-Peter Hartung, et al.
Brain : a Journal of Neurology|December 14, 2020
COVID-19 vaccine and Guillain-Barré syndrome: let's not leap to associationsMichael P Lunn, David R Cornblath, Bart C Jacobs, et al.
Drug Safety|June 28, 2023
Safety and Tolerability of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: Results of the ProCID StudyDavid R Cornblath, Pieter A van Doorn, Hans-Peter Hartung, et al.
Critical Care Medicine|January 5, 2010
A framework for diagnosing and classifying intensive care unit-acquired weaknessRobert D Stevens, Scott A Marshall, David R Cornblath, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
The Lancet. Neurology|May 12, 2019
Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathyCarina Bunschoten, Bart C Jacobs, Peter Y K Van den Bergh, et al.
Journal of Clinical Neuromuscular Disease|January 27, 2009
Peripheral nerve vasculitis presenting as complex regional pain syndromeSindhu Ramchandren, Vinay Chaudhry, Ahmet Hoke, et al.
Journal of the Peripheral Nervous System : JPNS|August 29, 2018
Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trialChrista Walgaard, Bart C Jacobs, Hester F Lingsma, et al.
Journal of the Peripheral Nervous System : JPNS|January 26, 2020
Boundaries of chronic inflammatory demyelinating polyradiculoneuropathyPeter Y K Van den Bergh, Pieter A van Doorn, Bart C Jacobs, et al.
Journal of the Peripheral Nervous System : JPNS|June 21, 2013
Rapid worsening of IgM anti-MAG demyelinating polyneuropathy during rituximab treatmentAbraham C J Stork, Nicolette C Notermans, Alexander F J E Vrancken, et al.
Vaccine|October 18, 2011
Guillain-Barré Syndrome in India: population-based validation of the Brighton criteriaFarrah J Mateen, David R Cornblath, Hamid Jafari, et al.
Brain : a Journal of Neurology|January 17, 2022
Randomized trial of three IVIg doses for treating chronic inflammatory demyelinating polyneuropathyDavid R Cornblath, Pieter A van Doorn, Hans-Peter Hartung, et al.
Brain : a Journal of Neurology|December 14, 2020
COVID-19 vaccine and Guillain-Barré syndrome: let's not leap to associationsMichael P Lunn, David R Cornblath, Bart C Jacobs, et al.
Drug Safety|June 28, 2023
Safety and Tolerability of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: Results of the ProCID StudyDavid R Cornblath, Pieter A van Doorn, Hans-Peter Hartung, et al.
Critical Care Medicine|January 5, 2010
A framework for diagnosing and classifying intensive care unit-acquired weaknessRobert D Stevens, Scott A Marshall, David R Cornblath, et al.
Pageof 10